Global Antidepressant Drugs Market – Analysis By Drugs

Class, By Sales Channel, By Region, By Country:

Opportunities and Forecasts (2018-2023)
• By Drugs Class - Tricyclic Antidepressants, Selective
Serotonin Reuptake Inhibitors, Selective -Norepinephrine
Reuptake Inhibitors, Monoamine Oxidase Inhibitors ,
Benzodiazepines. Antipsychotics, Novel Agents
• By Sales Channel - Hospital & Clinics, Retail Pharmacies,
Others
• By Region- APAC , North America, Europe and RoW
• By Country - United States, Canada, United Kingdom,
Germany, , China, India, Japan, Brazil, South Arabia

February
2018
Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By
Country: Opportunities and Forecasts (2018-2023) - By Region (APAC , N. America, Europe , RoW),
By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)
 Global Coverage  By Drugs Class  Region (North America, Europe, APAC, Rest of World )
Scope of the Study  Regional Coverage  By Sales Channels  Country (U.S., Canada, Germany, United Kingdom,
India, China, Japan, Brazil, South Arabia)
 Country Coverage

Regional Coverage Country Coverage Company Coverage

Global Coverage
 North America
 Europe  U.S.
 PFIZER INC.
 Asia Pacific  Canada
 Germany
 Rest of World  ELI LILLY
 Anti Depressants Drugs Market –  United Kingdom
 India
 Allergan
By Value (In USD Billion) -(2013-  China
 Japan
 Novartis
2023)  Brazil
 South Arabia
 Takeda
 By Drugs Class ( Tricyclic,
 GlaxoSmithkiline
Serotonin-Norepinephrine
 Antidepressant Drugs Market –
 Forest Laboratories
Inhibitors, Antipsychotics,
By Value (2013-2023)
Selective Srotonin Reuptake  Anti Depressant Drugs Market
 Segmentation By Drugs Class
Inhibitors, Benzodiazepines, – By Value (In USD Billion) -
 Segmentation By Sale
Monoamine Oxidase Inhibitors, (2013-2023)
Channels  Product Benchmarking
Novel Agents, Others)  Breakdown-By - Drugs Class
 Business Overview
 By Sales Channels (Hospitals & (2013-2023)
 Pipeline Analysis
Clinics, Retail Pharmacies,

Others)

2
 Table of Content
S.No Particulars Page No.

1. Research Methodology 18

2. Executive Summary 19

3. Strategic Recommendation 20

3.1 Focus on Asia Pacific Region 21

3.2 Focus on new antidepressant drugs development 22

4. Antidepressant Drugs Market Outlook 23

5. Global Antidepressant Drugs Market: Growth and Forecast 28

5.1 By Value (2013-2017) 29

5.2 By Value (2018-2023) 34

6. Global Antidepressant Drugs Market: By Drugs Class 35

6.1 Global Antidepressant Drugs Market-By Drugs Class: Breakdown(%) 35

6.1.1 Global Antidepressant Drugs Market Size and Share, By Drugs, 2017 36

6.1.2 Global Antidepressant Drugs Market Size and Share, By Drugs, 2023 37

6.2 Global Selective Serotonin Reuptake Inhibitors Market Overview 38

6.2.1 By Value (2013-2023) 38

3
 Table of Content
S. No Particulars Page No.

6.3 Global Serotonin and Norepinephrine Reuptake Inhibitors Market Overview 42

6.3.1 By Value (2013-2023) 42

6.4 Global Monoamine Oxidase Inhibitors Market Overview 44

6.4.1 By Value (2013-2023) 44

6.5 Global Tricyclic Antidepressant Drugs Market Overview 46

6.5.1 By Value (2013-2023) 46

6.6 Global Benzodiazepines Antidepressant Drugs Market Overview 48

6.6.1 By Value (2013-2023) 48

6.7 Global Antipsychotics Antidepressant Drugs Market Overview 50

6.7.1 By Value (2013-2023) 50

6.8 Global Novel Agents Antidepressant Drugs Market Overview 52

6.8.1 By Value (2013-2023) 52

6.9 Global Other Antidepressant Drugs Market Overview 53

6.9.1 By Value (2013-2023) 53

7. Global Antidepressant Drugs Market: By Sales Channels 54

7.1 Global Antidepressant Drugs Market-By Sales Channels : Breakdown(%) 54

7.1.1 Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2017 55

7.1.2 Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2023 56

4
 Table of Content
S. No Particulars Page No.

7.2 Global Antidepressant Drugs Market By Hospital & Clinics Overview 57

7.2.1 By Value (2013-2023) 57

7.3 Global Antidepressant Drugs Market By Retail Pharmacies Overview 58

7.3.1 By Value (2013-2023) 58

7.4 Global Antidepressant Drugs Market By Others Overview 59

7.4.1 By Value (2013-2023) 59

8. Global Antidepressant Drugs Market: Pipeline Analysis 60
8.1 By Developer, Phase, Indication and Status 61
9. Global Antidepressant Drugs Market: Regional Analysis 65
9.1 Global Antidepressant Drugs Market, By Region: Breakdown (%) 65
9.1.1 Global Antidepressant Drugs Market Size, By Region, 2017 (%) 66
9.1.2 Global Antidepressant Drugs Market Size, By Region, 2023 (%) 67

9.2 North America Antidepressant Drugs Market: An Analysis 68

9.2.1 By Value (2013-2017) 69
9.2.2 By Value (2018-2023) 70
9.3 North America Antidepressant Drugs Market: Segment Analysis 71
9.3.1 North America Antidepressant Drugs Market: By Drug Class 72

9.3.1.1 North America Antidepressant Drugs Market Size, By Value, 2013-2023 72

9.3.2 North America Antidepressant Drugs Market: By Sales Channels 74

9.3.2.1 North America Antidepressant Drugs Market Size, By Value, 2013-2023F 75

5
 Table of Content
S. No Particulars Page No.

9.4 North America Antidepressant Drugs Market: Country Analysis (U.S. and Canada) 76

9.4.1 U.S. Antidepressant Drugs Market, By Value (2013-2023) 79

9.4.1.1 U.S. Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 84

9.4.2 Canada Antidepressant Drugs Market, By Value (2013-2023) 87

9.4.2.2 Canada Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 89

9.5 Europe Antidepressant Drugs Market: An Analysis 91

9.5.1 By Value (2013-2017) 92

9.5.2 By Value (2018-2023) 93

9.6 Europe Antidepressant Drugs Market: Segment Analysis 94

9.6.1 Europe Antidepressant Drugs Market: By Drugs Class 94

9.6.1.1 Europe Antidepressant Drugs Market Size, By Value, 2013-2023 95

9.6.2 Europe Antidepressant Drugs Market: By Sales Channels 97

9.6.2.1 Europe Antidepressant Drugs Market Size, By Value, 2013-2023F 98

9.7 Europe Antidepressant Drugs Market: Country Analysis (U.K., Germany & Rest of Europe) 99

9.7.1 United Kingdom Antidepressant Drugs Market, By Value (2013-2023) 102

9.7.1.1 United Kingdom Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 106

9.7.2 Germany Antidepressant Drugs Market, By Value (2013-2023) 109

9.7.2.1 Germany Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 112

9.7.3 Rest of Europe Antidepressant Drugs Market, By Value (2013-2023) 114

6
 Table of Content
S. No Particulars Page No.

9.8 Asia Pacific Antidepressant Drugs Market: An Analysis 115

9.8.1 By Value (2013-2017) 116

9.8.2 By Value (2018-2023) 117

9.9 Asia Pacific Antidepressant Drugs Market: Segment Analysis 118

9.9.1 Asia Pacific Antidepressant Drugs Market: By Drugs Class 118

9.9.1.1 Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023 119

9.9.2 Asia Pacific Antidepressant Drugs Market: By Sales Channels 121

9.9.2.1 Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023F 122

9.10 Asia Pacific Antidepressant Drugs Market: Country Analysis (Germany, U.K., & Rest of Europe) 123

9.10.1 India Antidepressant Drugs Market, By Value (2013-2023) 126

9.10.1.1 India Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 130

9.10.2 China Antidepressant Drugs Market, By Value (2013-2023) 133

9.10.2.1 China Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 136

9.10.3 Japan Antidepressant Drugs Market, By Value (2013-2023) 140

9.10.3.1 Japan Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 143

9.10.4 Rest of Asia Pacific Antidepressant Drugs Market, By Value (2013-2023) 145

7
 Table of Content
S. No Particulars Page No.

9.11 Rest of World Antidepressant Drugs Market: An Analysis 146

9.11.1 By Value (2013-2017) 147

9.11.2 By Value (2018-2023) 148

9.12 Rest of World Antidepressant Drugs Market: Segment Analysis 149

9.12.1 Rest of World Antidepressant Drugs Market: By Drugs Class 149

9.12.1.1 Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023 150

9.12.2 Rest of World Antidepressant Drugs Market: By Sales Channels 152

9.12.2.1 Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023F 153

9.13 Rest of World Antidepressant Drugs Market: Country Analysis (Brazil, Saudi Arabia & Others) 154

9.13.1 Brazil Antidepressant Drugs Market, By Value (2013-2023) 157

9.13.1.1 Brazil Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 158

9.13.2 Saudi Arabia Antidepressant Drugs Market, By Value (2013-2023) 161

9.13.2.1 Saudi Arabia Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 162

9.13.3 Others Antidepressant Drugs Market, By Value (2013-2023) 164

8
 Table of Content
S. No Particulars Page No.

10. Market Dynamics 165

10.1 Drivers 166

10.2 Challenges 169

11. Market Trends 171

12. Policy and Regulatory Landscape 173

13. Porter’s Five Forces Analysis – Antidepressant Drugs Market 181

14. SWOT Analysis –Antidepressant Drugs Market 183

15. Company Profiling 185

15.1 Allergan 186

15.2 Eli Lilly 187

15.3 Pfizer 188

15.4 Takeda 190

15.5 GlaxoSmithKline 192

15.6 Novartis 193

15.7 Forest Laboratories 195

16. About Us 196

9
 List of Figures
Figure No. Figure Title Page No.

Figure 1: Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 29

Figure 2: Global YLDs of Depressive Disorders (2013-2016, %) 30

Figure 3: Global DALYs of Anxiety Disorders (2013-2016 %) 30
Figure 4: DALYs due to Mental and Substance Abuse (2016) 30
Figure 5: World Female Population, 2012-2016 (Million) 31
Figure 6: World Population 65 Years & Above (% of Total), 2012-2016 31
Figure 7: Global Unemployment (2016, 2017E, 2018F, (Millions) 32
Figure 8: Global Health Expenditure Per Capita, By Select Countries,(2016, USD) 33
Figure 9: Global Health Expenditure Per Capita, (2012-2016, USD Trillion) 33
Figure 10: Global Antidepressant Drugs Market Size, By Value, 2018-2023 (USD Billion) 34
Figure 11: Global Antidepressant Drugs Market Size, By Drugs, 2017 (%) 36
Figure 12: Global Antidepressant Drugs Market Size, By Drugs Class, 2023F (%) 37
Figure 13: Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD 38
Billion)
Figure 14: Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD 38
Billion)
Figure 15: SSRIs Antidepressants Usage in Different Disorders (%) 40
Figure 16: Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 42
(USD Billion)
Figure 17: Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E- 42
2023F (USD Billion)
Figure 18: Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 44
Figure 19: Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 44

10
 List of Figures
Figure No. Figure Title Page No.

Figure 20: Global Tricyclic Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 46

Figure 21: Global Tricyclic Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 46

Figure 22: Global Benzodiazepines Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 48

Figure 23: Global Benzodiazepines Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 48

Figure 24: Global Antipsychotics Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 50

Figure 25: Global Antipsychotics Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 50

Figure 26: Global Novel Agents Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 52

Figure 27: Global Novel Agents Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 52

Figure 28: Global Others Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 53

Figure 29: Global Others Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 53

Figure 30: Global Antidepressant Drugs Market Size, By Sales Channels, 2017 (%) 55

Figure 31: Global Antidepressant Drugs Market Size, By Sales Channels, 2023 (%) 56

Figure 32: Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2013-2017 (USD Billion) 57

Figure 33: Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2018E-2023F (USD Billion) 57

Figure 34: Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2013-2017 (USD Billion) 58

Figure 35: Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2018E-2023F (USD Billion) 58

Figure 36: Global Antidepressant Drugs Market, By Others, By Value, 2013-2017 (USD Billion) 59

Figure 37: Global Antidepressant Drugs Market, By Others, By Value, 2018E-2023F (USD Billion) 59

Figure 38: Global Antidepressant Drugs Market Size and Share, By Region, 2017 66

Figure 39: Global Antidepressant Drugs Market Size and Share, By Region, 2023F 67

11
 List of Figures
Figure No. Figure Title Page No.

Figure 40: North America Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 69
Figure 41: North America Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion) 70
Figure 42: North America Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 72
Figure 43: North America Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion) 75
Figure 44: North America Antidepressant Drugs Market, Country Share, 2017 (% of Total) 77
Figure 45: North America Antidepressant Drugs Market, Country Share, 2023 (% of Total) 77
Figure 46: United States Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 79
Figure 47: United States Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 79
Figure 48: United States YLDs by Anxiety Disorders (2013-2016 %) 80
Figure 49: United States YLDs by Depressive Disorders (2013-2016 %) 80
Figure 50: United States Prevalence of Different Types of Mental Disorders Among Different Age Group (2016) 80

Figure 51: United States Prevalence of Different Types of Mental Disorders Among Different Age Group (2016) 81

Figure 52: Treatment Received Among Adults with Major Depressive Episode (2016) 81

Figure 53: Per Capita Healthcare Expenditure in United States (2012-2016, USD) 82

Figure 54: U.S Health Spending by Type of Service or Product, 2016 (%) 82

Figure 55: U.S Health Spending by Type of Service or Product, 2016 (%) 84
Figure 56: Canada Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 87

Figure 57: Canada Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 87

Figure 58: Canada Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 89

Figure 59: Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 92

Figure 60: Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 93

12
 List of Figures
Figure No. Figure Title Page No.

Figure 61: Europe Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 95

Figure 62: Europe Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion) 98
Figure 63: Europe Antidepressant Drugs Market, Country Share, 2017 (% of Total) 100
Figure 64: Europe Antidepressant Drugs Market, Country Share, 2023 (% of Total) 100

Figure 65: United Kingdom Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 102

Figure 66: United Kingdom Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 102

Figure 67: United Kingdom YLDs by Depressive Disorders (2013-2016 %) 103

Figure 68: Antidepressant Dispensed in England (2005, 2015, 2016, Million Units) 103
Figure 69: United Kingdom YLDs by Anxiety Disorders (2013-2016 %) 103

Figure 70: Per Capita Healthcare Expenditure in United Kingdom (2012-2016, USD) 104

Figure 71: U.K. Population 65 Years & Above (% of Total), 2012-2016 104

Figure 72: United Kingdom Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 106

Figure 73: Germany Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 109

Figure 74: Germany Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 109

Figure 75: Private Healthcare Spending in Germany, US Dollar/capita (2012-2016) 110

Figure 76: Germany Per Capita Healthcare Expenditure (2012-2016, USD) 110

Figure 77: Germany YLDs & DALYs by Depressive Disorders (2013-2016 %) 110

Figure 78: Germany Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 112

Figure 79: Rest of Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 114

Figure 80: Rest of Europe Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 114

13
 List of Figures
Figure No. Figure Title Page No.

Figure 81: Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 116

Figure 82: Asia Pacific Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion) 117
Figure 83: Asia Pacific Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion 119
Figure 84: Asia Pacific Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion) 122

Figure 85: Asia Pacific Antidepressant Drugs Market, Country Share, 2017 (% of Total) 124
Figure 86: Asia Pacific Antidepressant Drugs Market, Country Share, 2023 (% of Total) 124
Figure 87: India Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 126
Figure 88: India Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 126

Figure 89: Prevalence of Depressive Disorders in India By Age and Sex- (2015-2016) 127

Figure 90: India Healthcare Expenditure (2012-2016, USD Billion) 128

Figure 91: India Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 130

Figure 92: China Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 134

Figure 93: China Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 134
Figure 94: China YLDs by Anxiety Disorders (2013-2016 %) 135

Figure 95: China YLDs & DALYs by Depressive Disorders (2013-2016 %) 135

Figure 96: China Healthcare Expenditure (2012-2016, USD Billion) 136

Figure 97: China Population 65 Years & Above (% of Total), 2012-2016 136

Figure 98: China Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 137

Figure 99: Japan Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 140

Figure 100: Japan Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 140

14
 List of Figures
Figure No. Figure Title Page No.

Figure 101: Japan Per Capita Health Expenditure (2012-2016, USD) 141

Figure 102: Japan YLDs by Depressive Disorders (2013-2016 %) 141

Figure 103: Japan YLDs by Depressive Disorders (2013-2016 %) 141

Figure 104: Japan Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 143

Figure 105: Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 145

Figure 106: Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 145

Figure 107: Rest of World Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 147

Figure 108: Rest of World Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion) 148

Figure 109: Rest of World Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 150

Figure 110: Rest of World Antidepressant Drugs Market: By Sales Channels, By Value, 2013-2023 (USD Billion) 153

Figure 111: Rest of World Antidepressant Drugs Market, Country Share, 2017 (% of Total) 155

Figure 112: Rest of World Antidepressant Drugs Market, Country Share, 2023 (% of Total) 155

Figure 113: Brazil Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 157

Figure 114: Brazil Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 157

Figure 115: Brazil Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 158

Figure 116: Saudi Arabia Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 161

15
 List of Figures
Figure No. Figure Title Page No.

Figure 117: Saudi Arabia Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 162

Figure 118: Saudi Arabia Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion) 162

Figure 119: Others Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 164

Figure 120: Others Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 164

Figure 121: Pfizer Segmental Breakup, 2016 (%) 189

Figure 122: Pfizer Sales, By Region, 2016 (%) 189

Figure 123: Takeda Segmental Break Up 191

Figure 124: Takeda Geographical Break Up 191

Figure 125: Novartis Sales, By Segment 2015 (%) 194

Figure 126: Novartis Sales, By Region, 2015 (%) 194

Figure 127: Novartis Pharmaceuticals Sales, By Franchise, 2015 (%) 194

16
 List of Tables
Table No. Table Title Page No.

Table A: List of Major Antidepressant Drugs Include in SSRIs Class 39

Table B: Licenced Indication of SSRIs 41

Table C: List of Major Antidepressant Drugs Include in SNRIs Class 43

Table D: List of Major Antidepressant Drugs Include in MAOIs Class 45

Table E: List of Major Antidepressant Drugs Include in Tricyclic Class 47

Table F: List of Major Antidepressant Drugs Include in Tetracyclic Class 47

Table G: List of Major Antidepressant Drugs Include in Benzodiazepines 48

Table H: List of Major Antidepressant Drugs Include in Antipsychotics 51

Table I: Antidepressant Drugs Market Analysis, By Drug, Developer, Phase, Indication 61

Table J: Facts and Figures Driving High Demand of Antidepressants in United States Market 81

17
 Research Methodology

Research Definition

Global Antidepressant Drugs Market Report comprises of the study of various aspects of antidepressants and
forecast until 2023. Global Antidepressant Drugs Market has been segmented on basis of Drugs
Class(Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake
Inhibitors, Monoamine Oxidase Inhibitors , Benzodiazepines Antipsychotics Novel Agents); By Sales Channels
(Hospital& Clinics, Retail Pharmacies, Others), By Region (North America, Europe, APAC, Middle East and ROW)
and By Country (U.S., Canada, Germany, United Kingdom, China, India, Japan, Brazil, Saudi Arabia,).

Data Analysis and Interpretation

Our historic market trend has been figured out by various paid databases which was further triangulated with
inputs and insights from industry experts, companies and stakeholders, through primary research
(manufacturers, marketing managers, others). Back-of-the-Envelope calculation for the market estimation has
been made through proper understanding of the market as well as future business strategies of the companies
operating in the market.

Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market

segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive primary surveys by

reaching out industry experts across the value chain of the global orthopeadic market.

Companies Contacted: Apollo Pharmacy

18
 Global Antidepressant Drugs Market Overview
Global Antidepressant Drugs Market has been driven by rising prevalence of depression and anxiety
disorders worldwide

Figure : Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)

CAGR 2013-2017
xxxx%

2013 2014 2015 2016 2017

Source: Azoth Analytics Estimates

Xxxx

Xxxx

Xxxx

Xxxx

Xxxx

Xxxx

xxxx

19
Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market
Overview
Figure : Global Monoamine Oxidase Inhibitors Antidepressant Figure : Global Monoamine Oxidase Inhibitors Antidepressant
Drugs Market, By Value, 2013-2017 (USD Billion) Drugs Market, By Value, 2018E-2023F (USD Billion)

CAGR 2013-2017 CAGR 2018-2023

xx% xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Source: Azoth Analytics Estimates

Xxxxx

Xxxxx

Xxxxx

Xxxxx

Xxxxx

xxxxx

20
 Global Antidepressant Drugs Market - By Sales Channels

In the forecast period, Retail Pharmacies are expected to account for the largest share in the market (45.34%)
but the Other segment estimated to be the faster growing region.

Figure: Global Antidepressant Drugs Market Size, Key Drivers

By Sales Channels, 2023 (%)

Xxxxx

Hospitals & Clinics xxxxx

Retail Pharmacies

Xxxxx

Others xxxxx

Source: Azoth Analytics Estimates

21
 Germany Antidepressant Drugs Market, By Drugs Class

Figure : Germany Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)

CAGR 2013-2017 CAGR 2018-2023

TCAs: xx%; SSRIs: xx%; SNRIs; xx%; TCAs: xx%; SSRIs: xx%; SNRIs; xx%;
MAOIs: xx%; Benzodiazepines: xx%; MAOIs: xx%; Benzodiazepines: xx%;
Antipsychotics: xx%; Novel Agents: xx; Antipsychotics: xx%; Novel Agents: xx;
Others: xx% Others: xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Source: Azoth Analytics Estimates

22
 United States Antidepressant Drugs Market, By Drugs Class

Figure 55: United States Antidepressant Drugs Market: By Drugs Class, By Value, 2013-2023 (USD Billion)

CAGR 2013-2017 CAGR 2018-2023

TCAs: 1.82%; SSRIs: 2.75%; SNRIs; TCAs: 2.42%; SSRIs: 3.20%; SNRIs;

2.82%; MAOIs: 1.83%; Benzodiazepines: 3.23%; MAOIs: 2.36%; Benzodiazepines:

2.26%; Antipsychotics: 0.73%; Novel 0.23%; Antipsychotics: 0.57%; Novel

Agents: 3.22%; Others:3.30% Agents: 3.73%; Others:5.78 %

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Tricyclic Antidepressants (TCAs)
Selective Serotonin Reuptake (SSRIs)
Serotonin-Norepinephrine Reuptake Inhibitors
(SNRIs)
Monoamine Oxidase Inhibitors (MAOIs)
Benzodiazepines
Antipsychotics
Novel Agents
Others

Source: Azoth Analytics Estimates

23
Report Ordering

Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities
and Forecasts (2018-2023) -- By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China,
India, Japan, Brazil, South Arabia)

Publish Date: Feb 2018

No. of Pages: 195
Price: USD 2400 (Single User License)
Price: USD 3000 (Multi- User License)

To View Sample Report or Purchase Report Click Here

Contact Us
ASIA PACIFIC EUROPE
Mail: info@azothanalytics.com Mail: shipra@azothanalytics.com
Phone: +91 120 429 8235 Phone: +44 - 744 - 8107625
NORTH AMERICA Call for Assistance
Mail: tanvi@azothanalytics.com Phone: +91 9873 4262 88
Phone: +1 - 321 - 444 9707 Sales Enquiry
Phone: +91 120 429 8235
www.azothanalytics.com
24
About Azoth Analytics Pvt Ltd.

Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy
services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food &
beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic
market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).

Related Reports:

Global Vitreoretinal Surgery Devices Market (By Product, By End User, By Region, By Country): Opportunities and Forecast (2016-2021)
– By Product (Vitrectomy Machines & Packs, Photocoagulation Surgery Devices, Illumination Devices, Others); By End User (Hospitals, Free Standing
Ambulatory Surgery Center); By Region (North America, Europe, APAC, ROW); By Country (US, Canada, Mexico, UK, Germany, France, Japan, China,
India, Brazil, South Africa)

Global Biomaterials Market (By Type, By Applications, By Region): Opportunities and Forecasts (2016-2021) - (By Material Type – Polymer,
Ceramic, Metal; By Appliactions - Orthopaedic, Cardiovascular, Plastic Surgery, Wound Care); By Region-North America, Europe, APAC, ROW; By Country
– US, UK, Germany, Italy, Japan, China, India; Key Players – Strategy, Financial Performance)

Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for
any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not warranty the completeness of the information and data. Also, analysis
provided in the report are meant for customers’ internal use only and not for general publication or disclosure to third parties.

24